[Controlled double-blind study on the effectiveness and tolerability of a combination therapy in chronic alcoholic liver diseases].
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D004311:Double-Blind Method; D004338:Drug Combinations; D005234:Fatty Liver / Q000188:drug therapy*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy*; D008297:Male; D010919:Placebos; D012709:Serum Albumin / Q000096:biosynthesis; D014815:Vitamins / Q000627:therapeutic use*; D005723:gamma-Glutamyltransferase / Q000378:metabolism
D004338:Drug Combinations; D010919:Placebos; D012709:Serum Albumin; D014815:Vitamins; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Kontrollierte Doppelblind-Studie auf Effektivität und Verträglichkeit einer Kombinationstherapie bei chronischen alkoholischen Lebererkrankungen.